CVE-2007-6763 - Vulnerability Details - OpenCVE

Description

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Published: 2019-07-31

Score: 8.8 High

EPSS: < 1% Very Low

KEV: No

Impact:

Action:

Analysis

Analysis and contextual insights are available on OpenCVE Cloud.

Default status is the baseline for the product, each version can override it (e.g. patched versions marked unaffected).

Vendor Product Default status Versions

n/a

n/a

affected

Version	Status	Constraints
`n/a`	affected	—

Configuration 1 [-]

cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*

No data.

No data available yet.

Remediation

No vendor fix or workaround currently provided.

Additional remediation guidance may be available on OpenCVE Cloud.

Tracking

Sign in to view the affected projects.

Advisories

Source	ID	Title
EUVD	EUVD-2007-6719	SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

No CVSS v4.0

No CVSS v3.1

Attack Vector Network

Attack Complexity Low

Privileges Required Low

Scope Unchanged

Confidentiality Impact High

Integrity Impact High

Availability Impact High

User Interaction None

Access Vector Network

Access Complexity Low

Authentication Single

Confidentiality Impact Partial

Integrity Impact Partial

Availability Impact Partial

This CVE is not in the KEV list.

The EPSS score is 0.00485.

Key SSVC decision points have not yet been added.

References

Link	Providers
http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf

History

No history.

Subscriptions

Sas Sas Drug Development

MITRE

Status: PUBLISHED

Assigner: mitre

Published: 2019-07-31T17:08:43.000Z

Updated: 2024-08-07T16:18:20.755Z

Reserved: 2019-07-30T00:00:00.000Z

Link: CVE-2007-6763

Vulnrichment

No data.

NVD

Status : Modified

Published: 2019-07-31T18:15:10.753

Modified: 2024-11-21T00:40:56.700

Link: CVE-2007-6763

Redhat

No data.

OpenCVE Enrichment

No data.

Weaknesses

CWE-20

{"containers": {"cna": {"affected": [{"product": "n/a", "vendor": "n/a", "versions": [{"status": "affected", "version": "n/a"}]}], "descriptions": [{"lang": "en", "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."}], "problemTypes": [{"descriptions": [{"description": "n/a", "lang": "en", "type": "text"}]}], "providerMetadata": {"dateUpdated": "2019-07-31T17:08:43.000Z", "orgId": "8254265b-2729-46b6-b9e3-3dfca2d5bfca", "shortName": "mitre"}, "references": [{"tags": ["x_refsource_MISC"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}], "x_legacyV4Record": {"CVE_data_meta": {"ASSIGNER": "cve@mitre.org", "ID": "CVE-2007-6763", "STATE": "PUBLIC"}, "affects": {"vendor": {"vendor_data": [{"product": {"product_data": [{"product_name": "n/a", "version": {"version_data": [{"version_value": "n/a"}]}}]}, "vendor_name": "n/a"}]}}, "data_format": "MITRE", "data_type": "CVE", "data_version": "4.0", "description": {"description_data": [{"lang": "eng", "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."}]}, "problemtype": {"problemtype_data": [{"description": [{"lang": "eng", "value": "n/a"}]}]}, "references": {"reference_data": [{"name": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf", "refsource": "MISC", "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}]}}}, "adp": [{"providerMetadata": {"orgId": "af854a3a-2127-422b-91ae-364da2661108", "shortName": "CVE", "dateUpdated": "2024-08-07T16:18:20.755Z"}, "title": "CVE Program Container", "references": [{"tags": ["x_refsource_MISC", "x_transferred"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}]}]}, "cveMetadata": {"assignerOrgId": "8254265b-2729-46b6-b9e3-3dfca2d5bfca", "assignerShortName": "mitre", "cveId": "CVE-2007-6763", "datePublished": "2019-07-31T17:08:43.000Z", "dateReserved": "2019-07-30T00:00:00.000Z", "dateUpdated": "2024-08-07T16:18:20.755Z", "state": "PUBLISHED"}, "dataType": "CVE_RECORD", "dataVersion": "5.1"}

{"configurations": [{"nodes": [{"cpeMatch": [{"criteria": "cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*", "matchCriteriaId": "FCB9AF1A-F40F-441A-9B94-4955D92C9655", "versionEndExcluding": "32drg02", "vulnerable": true}], "negate": false, "operator": "OR"}]}], "descriptions": [{"lang": "en", "value": "SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser."}, {"lang": "es", "value": "SAS Drug Development (SDD) anterior de 32DRG02 maneja mal las acciones de cierre de sesi\u00f3n, lo que permite a un usuario (que hab\u00eda iniciado sesi\u00f3n previamente) acceder a los recursos presionando un bot\u00f3n de retroceso o avance en un navegador web"}], "id": "CVE-2007-6763", "lastModified": "2024-11-21T00:40:56.700", "metrics": {"cvssMetricV2": [{"acInsufInfo": false, "baseSeverity": "MEDIUM", "cvssData": {"accessComplexity": "LOW", "accessVector": "NETWORK", "authentication": "SINGLE", "availabilityImpact": "PARTIAL", "baseScore": 6.5, "confidentialityImpact": "PARTIAL", "integrityImpact": "PARTIAL", "vectorString": "AV:N/AC:L/Au:S/C:P/I:P/A:P", "version": "2.0"}, "exploitabilityScore": 8.0, "impactScore": 6.4, "obtainAllPrivilege": false, "obtainOtherPrivilege": false, "obtainUserPrivilege": false, "source": "nvd@nist.gov", "type": "Primary", "userInteractionRequired": false}], "cvssMetricV30": [{"cvssData": {"attackComplexity": "LOW", "attackVector": "NETWORK", "availabilityImpact": "HIGH", "baseScore": 8.8, "baseSeverity": "HIGH", "confidentialityImpact": "HIGH", "integrityImpact": "HIGH", "privilegesRequired": "LOW", "scope": "UNCHANGED", "userInteraction": "NONE", "vectorString": "CVSS:3.0/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H", "version": "3.0"}, "exploitabilityScore": 2.8, "impactScore": 5.9, "source": "nvd@nist.gov", "type": "Primary"}]}, "published": "2019-07-31T18:15:10.753", "references": [{"source": "cve@mitre.org", "tags": ["Vendor Advisory"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}, {"source": "af854a3a-2127-422b-91ae-364da2661108", "tags": ["Vendor Advisory"], "url": "http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf"}], "sourceIdentifier": "cve@mitre.org", "vulnStatus": "Modified", "weaknesses": [{"description": [{"lang": "en", "value": "CWE-20"}], "source": "nvd@nist.gov", "type": "Primary"}]}